Scroll Back to Top
An African woman with cancer is happily spending time with her adult son in a living room. They are laughing and being affectionate.

2023 ASCO Annual Meeting 

Thank you for joining us

supporting image

Thank you for joining us at 2023 ASCO Annual Meeting in Chicago.  It was a pleasure to meet with everyone who came to visit with us. 

If you did not get a chance to meet with us, or have a question and would like someone to contact you, please click on the contact button below.  

  • VIEW OUR POSTERS & ONLINE PUBLICATIONS
     

    Track: Breast Cancer

    #250   Effect of homologous recombination deficient (HRD) breast cancers on a distinct immune marker phenotype by comprehensive genomic and immune profiling (CGIP) 
    Authors: Heidi Chwan Ko, Sarabjot Pabla, Mary K Nesline, Kyle C Strickland, Rebecca A Previs, Zachary D Wallen, Shengle Zhang, Jeffrey M Conroy, Mark Sausen, Jennifer B Jackson, Kamal S Saini, Scott Wise, Taylor J Jensen, Venkataprasanth P. Reddy, Eric A Severson, Shakti Ramkissoon 
    Session Title: Breast Cancer - Metastatic  
    View poster

    #251   Comparison of immune microenvironment between primary and metastatic breast tumors 
    Authors: Heidi Chwan Ko, Sarabjot Pabla, Mary K Nesline, Shipra Gandhi, Kyle C Strickland, Rebecca A Previs, Zachary D Wallen, Shengle Zhang, Jeffrey M Conroy, Mark Sausen, Jennifer B Jackson, Kamal S Saini, Scott Wise, Taylor J Jensen, Venkataprasanth P. Reddy, Eric A Severson, Shakti Ramkissoon
    Session Title: Breast Cancer - Metastatic 
    View poster

    #e13085   Reliance of agency-approved and guideline-recommended therapies on surrogate endpoints in triple-negative breast cancer (TNBC) 
    Authors: Kinisha Gala, Ankit Kalucha, Judith Pérez-Granado, Maria Garcia Requesens, Laura Vidal, Bruno L Larvol, Mark Gramling, Kamal S. Saini
    Session Title: Publication Only - Breast Cancer - Metastatic - Triple-Negative
    View abstract

    #e13089   Correlation analysis to assess surrogate endpoints for overall survival (OS) in Triple-Negative Breast Cancer (TNBC)
    Authors: Judith Pérez-Granado, Ankit Kalucha, Kinisha Gala, Olga Bodriagova, Laura Vidal, Bruno L Larvol, Mark Gramling, Kamal S. Saini
    Session Title: Publication Only - Breast Cancer - Metastatic - Triple-Negative
    View abstract

    Track: Care Delivery and Regulatory Policy

    #206a   Liquid biopsy-informed precision oncology study to evaluate utility of plasma genomic profiling for therapy selection
    Authors: Jessica Tao, Jenna Canzoniero, Maria Fatteh, Timsy Wanchoo, Archana Balan, Rena Xian, Peggy Fitzpatrick, Taxiarchis Botsis, Mark Sausen, Valsamo Anagnostou
    Session Title: Care Delivery and Regulatory Policy - Practice Management

    #e13630   Decentralized Elements within Oncology Trials: Labcorp Experience
    Authors: Alicia Rami, Maria Alcaide, Begoña de las Heras, Laura Vidal, Joanna Pascual, Kurt Lumsden
    Session Title: Care Delivery and Regulatory Policy - Technology/Therapeutics
    View abstract

    Track: Developmental Therapeutics

    #298   First-in-human phase 1 study of pimicotinib (ABSK021), a CSF-1R inhibitor, in patients with advanced solid tumors
    Authors: Gerald Falchook, Yongmei Yin, R. Donald Harvey, Siqing Fu, Weitao Yao, Yanru Qin, Xiaojing Zhang, Qingping Zou, Boyao Shan, Pan Liang, Chen Wang, Wenjia Li, Zehra Nurgul Pamuklar, Yi Pei, Zhiwei Chang, Jiaqiang Wang, Sarina A. Piha-Paul, Manali Bhave, Yan Liang, Jason Timothy Henry
    Session Title: Developmental Therapeutics - Molecularly Targeted Agents and Tumor Biology - Small Molecules
    View poster

    #308   First-in-human (FIH) phase I dose escalation study (Part A) of the first oral allosteric modulator of phosphoinositide 3-kinase inhibitor delta (PI3Kδ) roginolisib in patients with advanced cancer and dose confirmation in Uveal Melanoma (Part B)
    Authors: Anna Maria Di Giacomo, Federica Santangelo, Giovanni Amato, Elena Simonetti, Jill Graham, Michael M. F. Lahn, Giusy Di Conza, Tracey Hammett, Rebeca Zorrilla, Marco Durini, Ziyang Tan, Lakshmikanth Tadepally, Petter Brodin, Mariaelena Occhipinti, Matteo Simonelli, Carmelo Carlo-Stella, Armando Santoro, Pavlina Spiliopoulou, T.R. Jeffry Evans, Michele Maio
    Session Title: Developmental Therapeutics - Molecularly Targeted Agents and Tumor Biology - Small Molecules
    View poster

    #456   Pan-cancer analysis of IDO1 transcriptome expression and its impact on outcome in patients treated with immune checkpoint inhibitors
    Authors: Yu Fujiwara, Shumei Kato, Daisuke Nishizaki, Hirotaka Miyashita, Suzanna Lee, Mary K Nesline, Jeffrey M Conroy, Paul DePietro, Sarabjot Pabla, Scott Lippman, Razelle Kurzrock
    Session Title: Developmental Therapeutics - Immunotherapy - Tissue-Based Biomarkers
    View poster

    #e14641   BTLA transcriptomic expression correlates with high levels of PD-1, PD-L2 and CTLA-4 checkpoints and with its ligand, HVEM, across diverse solid cancers
    Authors: Sharon Choi, Razelle Kurzrock, Thomas O'Keefe, Daisuke Nishizaki, Hirotaka Miyashita, Suzanna Lee, Mina Nikanjam, Ramez Nassef Eskander, Hitendra Patel, Gregory P. Botta, Sarabjot Pabla, Mary K Nesline, Jeffrey M. Conroy, Paul DePietro, Jason K. Sicklick, Shumei Kato
    Session Title: Publication Only - Developmental Therapeutics - Immunotherapy - Tissue-Based Biomarkers
    View abstract

    #e14561   Implications of GITR expression profile for precision immunotherapeutics
    Authors: Peter Moussa, Razelle Kurzrock, Daisuke Nishizaki, Hirotaka Miyashita, Suzanna Lee, Mina Nikanjam, Ramez Eskander, Hitendra Patel, Gregory Botta, Sarabjot Pabla, Mary K Nesline, Jeffrey M Conroy, Paul DePietro, Jason K Sicklick, Shumei Kato
    Session Title: Publication Only - Developmental Therapeutics - Immunotherapy - Immunobiology
    View abstract

    #e14669   Relationship between ICOS and ICOS Ligand RNA expression patterns with tumor type, tumor mutational burden, and clinically relevant immune checkpoints
    Authors: Mina Nikanjam, Shumei Kato, Daisuke Nishizaki, Donald A. Barkauskas, Sarabjot Pabla, Mary Nesline, Jeffrey M. Conroy, Aung Naing, Razelle Kurzrock
    Session Title: Publication Only - Developmental Therapeutics - Immunotherapy - Other Checkpoint Inhibitors (Monotherapy or Combination)
    View abstract

    #e14637   TIGIT transcriptomic expression correlates with high levels of multiple checkpoints across diverse cancers
    Authors: Jacob J. Adashek, Shumei Kato, Sarabjot Pabla, Mary Nesline, Jeffrey M. Conroy, Paul DePietro, Razelle Kurzrock
    Session Title: Publication Only - Developmental Therapeutics - Immunotherapy - Tissue-Based Biomarkers
    View abstract

    Track: Gynecologic Cancer

    #274   Molecular and immune profiling of TP53-mutated ovarian cancers with non-BRCA1/2 homologous recombination gene alterations
    Authors: Kyle C Strickland, Rebecca A Previs, Zachary D Wallen, Mary K Nesline, Heidi Chwan Ko, Sarabjot Pabla, Stephanie Hastings, Taylor J Jensen, Prasanth Reddy, Eric A Severson, Shakti Ramkissoon
    Session Title: Gynecologic Cancer - Ovarian
    Session Type: Poster Session
    View poster

    #5594   Healthcare access dimensions and uterine cancer survival: A National Cancer Database study
    Authors: Mary Katherine Anastasio, Anjali Gupta, Tomi F. Akinyemiju, Rebecca A. Previs
    Session Title: Gynecologic Cancer - Ovarian
    View poster

    #e17548   A Real-World Study of US Patients with Metastatic Ovarian, Fallopian Tube and Peritoneal Cancer (mOFPC) using Integrated Electronic Health Records (EHR) and Claims Datasets
    Authors: Avinash PB, Gabriel Funingana, Neeraj Singh, Rohini George, Anna Sowa, Sangavai Chakkrapani, Vandana Priya, Vivek Vaidya, Laura Vidal, Kamal S Saini, Smita Agrawal
    Session Title: Gynecologic Cancer - Ovarian
     

    Track: Health Services Research and Quality Improvement

    #6506  The impact of single gene testing (SGT) on subsequent comprehensive genomic profiling (CGP) success in community oncology practice for advanced non-small cell lung cancer (NSCLC): Results from a prospective observational reference laboratory testing program
    Authors: Mary Nesline, Paul DePietro, Maureen Cooper, Shengle Zhang, Sarah Howarth, Zachary Wallen, Michael Biorn, Kyle Strickland, Rebecca Previs, Heidi Ko, Mark Sausen, Jennifer Jackson, Kamal Saini, Scott Wise, Taylor Jensen, Sarabjot Pabla, Jeffrey Conroy, Prasanth Reddy, Eric Severson, Shakti Ramkissoon
    Session Title: Health Services Research and Quality Improvement - Quality of Care/Quality Improvement
    Session Type: Oral Abstract

    #6590 Site of metastasis and its impact on clinical outcomes in 8 cancer cohorts
    Authors: Rohini George, Laura Vidal, Dorota Skalska, Kamal S Saini, et al.
    Session Title: Health Services Research and Quality Improvement - Real-World Data/Outcomes
    View poster

    Track: Lung Cancer

    #e21110  TIGIT expression and outcomes in pembrolizumab treated patients with NSCLC
    Authors: Maria-Fernanda Senosain, Robert Seager, Erik Van Roey, Shuang Gao, Paul DePietro, Mary Nesline, Durga Dash, Jeffrey Conroy, Stephanie Hastings, Heidi Ko, Kyle Strickland, Rebecca Previs, Eric Severson, Taylor Jensen, Venkataprasanth Reddy, Shakti Ramkissoon, Sarabjot Pabla
    Session Title: Lung Cancer - Non-Small Cell Lung Cancer - Advanced/Metastatic Disease
    View abstract

    #e21113   LAG3 landscape in solid tumors and its association with immunotherapy outcomes in non-small cell lung cancer
    Authors: R.J. Seager, Maria-Fernanda Senosain, Erik Van Roey, Shuang Gao, Paul DePietro, Mary Nesline, Durga prasad Dash, Jeffrey M Conroy, Heidi Ko; Stephanie Hastings; Kyle C Strickland, Rebecca Ann Previs; Eric Allen Severson; Taylor J Jensen; Prasanth Reddy; Shakti Ramkissoon; Sarabjot Pabla
    Session Title: Lung Cancer - Non-Small Cell Lung Cancer - Advanced/Metastatic Disease
    View abstract

    #e21155   Prevalence of KRAS p.G12C mutation in patients with metastatic non-small cell lung cancer in Argentina
    Authors: Andrea Mendoza Bertelli, Maria Otero Pizarro, Maria Fernandez, Delfina Dibarbora, Maria Cantarella, Yamil Mahmoud, Romina Girotti, Leandro Guttlein, Isagani Chico, Patrícia Brandalise, Carolina Dutra, Ruben Salanova  
    Session Title: Lung Cancer - Non-Small Cell Lung Cancer - Advanced/Metastatic Disease
    View poster

    Track: Prevention, Risk Reduction, and Hereditary Cancer

    #e22538   Real-world clinical and genomic analysis of patients with a personal or family history of cancer undergoing germline testing for BRCA1 and BRCA2
    Authors: Rebecca A Previs, Heidi Chwan Ko, Zachary D Wallen, Kyle C Strickland, Mary K Nesline, Dagny Noeth, Melissa Hayden, Sabrina Gardner, Ruth A Heim, Taylor J Jensen, Prasanth Reddy, Eric A Severson, Shakti Ramkissoon
    Session Title: Publication Only: Prevention, Risk Reduction, and Hereditary Cancer - Germline Genetic Testing
    View abstract

Get Email Updates

Stay current by signing up to receive the latest news and updates on tests and services.